Key Facts About TrumpRx Drug Discounts

So far, TrumpRx only includes the branded versions of medications, offering no generic options.
Key Facts About TrumpRx Drug Discounts
Retno Aditya/Shutterstock
|Updated:
0:00

People paying for drugs out of pocket may now be able to enjoy cheaper drug prices for a select number of medications.

On Feb. 5, President Donald J. Trump launched TrumpRx, a website that offers coupons for more than 40 different medications at discounted prices. Additional discounted drugs may be added to the website’s list.

TrumpRx is not a website for buying drugs. The website provides discount coupons for medications that patients can print out and bring into participating pharmacies, with the biggest participating pharmacy being CVS Caremark.

David Lejeune, president of America’s HealthShare, described TrumpRx as a “clearinghouse of sorts” that will guide people to more affordable prescription drugs.

So far, TrumpRx only includes the branded versions of medications, offering no generic options.

Who Will Benefit

Consumers who are not medically insured or are paying for any of the 43 medications out of pocket may benefit from TrumpRx.

Almost everyone would be able to use TrumpRx to access drugs at the offered price. However, people who are on insurance are encouraged to check with their insurance provider because they may be able to get a cheaper price with their coverage.

Patients on government-funded insurance and benefits like Medicare, Medicaid, and Veterans Affairs may not be eligible for discounts on a few drugs such as Ozempic and Wegovy.

Common medications included are:
  • Zepbound and Orforglipron: dropping from $1,086 to approximately $346 monthly
  • Emgality (migraine treatment): $299 per pen, a $443 discount
  • Trulicity (diabetes): $389 per month, a $598 discount
  • Protonix (acid reflux): $200 per month, a $247 discount.
  • Azulfidine (arthritis): $131 for 120 tablets, a $131 discount.
  • Insulin products including NovoLog and Tresiba: $35 per month
It should be noted that discounts are subject to change and certain drugs’ discounts may be temporary. For example, the Wegovy pens are subject to a $199 discount per month for only two months before switching back to $349/month.
The discounted drug prices are only available at participating pharmacies like CVS Caremark, Alto Pharmacy, and a select few private pharmacies in other states.

Insured People Should Compare Prices

Patients who already have insurance should check the prices offered by their own insurer before considering TrumpRx discounts, since insurance may offer a cheaper price.

Insurance Provider’s Website or App

Many insurance companies offer online portals or mobile apps where you can log in and view the cost of specific medications based on your coverage. Simply search for the drug name to see the estimated copay or out-of-pocket expense.
People with Medicare and other government-funded insurance can check their pricing through government websites.

Drug Price Comparison Tools

Websites like GoodRx, SingleCare, and WellRx allow you to compare prices at different pharmacies in your area. These platforms often include information on whether your insurance covers the medication or if you can save more by paying out of pocket.

Pharmacies’ Price Check

Pharmacies have different prices depending on insurance. Call or visit local pharmacies directly and ask for the cash price of the medication. Some pharmacies can provide an immediate quote that you can compare with the price listed on your insurance provider’s platform.

Other Ways to Get Discounts

For some medications like Wegovy and Zepbound, people can directly reach out to the drug company for the same discount. Wegovy currently offers the same $199 per month discount on its website for its Wegovy pens.

Since TrumpRx currently only provides branded options, getting a generic prescription when available could further reduce expenditure.

George Citroner
George Citroner
Author
George Citroner reports on health and medicine, covering topics that include cancer, infectious diseases, and neurodegenerative conditions. He was awarded the Media Orthopaedic Reporting Excellence (MORE) award in 2020 for a story on osteoporosis risk in men.